Welcome
Support Centre
04 February 2012 
ISRCTN Register - International Standard Randomized Controlled Trial Number
Trial registration
Unique identification scheme
International databases
home  |   my details  |   ISRCTN Register  |   mRCT  |   links  |   information  |   press
Find trials
ISRCTN Register
tips on searching

Registration
New application
Updating record

Information
introduction
governing board
ISRCTN FAQs
data set
letter of agreement
request information
guidance notes

[ Print-friendly version ]
Physical activity to persons with fibromyalgia and osteoporosis
ISRCTN ISRCTN83162243
ClinicalTrials.gov identifier
Public title Physical activity to persons with fibromyalgia and osteoporosis
Scientific title
Acronym AFPFO/05/02
Serial number at source 05/02
Study hypothesis 1. Physical activity enhances the
health related to quality of life and physical fitness
2. Aquatic training is a cost-effective strategy in persons with fibromyalgia
Lay summary
Ethics approval Approved by the Bioethical Committee of University of Extremadura on 10/02/2002 ( ref: 05/02)
Study design Randomised controlled trial
Countries of recruitment Spain
Disease/condition/study domain Fibromyalgia
Participants - inclusion criteria Women who suffer fibromyalgia according to American College of Rheumatism diagnosis
Participants - exclusion criteria 1. Contraindications to physical exercise
2. Other physical or psychological therapies
3. Cognitive disease
4. Drugs affecting the measures
Anticipated start date 01/04/2004
Anticipated end date 01/10/2004
Status of trial Completed
Patient information material
Target number of participants 65 distributed in three groups
Interventions Patients are randomised to three groups:
Group 1: Aquatic training, 3 sessions per week for 3 months - 18 patients
Group 2: Usual care - 17 patients
Group 3: Land-based training, 3 sessions per week for 3 months - 30 patients
Primary outcome measure(s) Group 1 versus Group 2 = Isokinetic strength and electromyographic parameters, health related quality of life -Fibromyalgia Impact Questionnaire, EQ5D and SF-36 and its utilities to study cost-effectiveness, fitness, costs
Group 1 versus Group 3 = Health related quality of life -Fibromyalgia Impact Questionnaire, EQ5D and SF-36 and its utilities to study cost-effectiveness, fitness, costs
Group 2 versus Group 3 = Health related quality of life -Fibromyalgia Impact Questionnaire, EQ5D and SF-36 and its utilities to study cost-effectiveness, fitness, costs
Secondary outcome measure(s) Group 1 versus Group 2 = Psychological aspects - State Trait Anxiety Inventory
Group 1 versus Group 3 = Psychological aspects - State Trait Anxiety Inventory
Group 2 versus Group 3 = Psychological aspects - State Trait Anxiety Inventory
Sources of funding Health Department of Junta de Extremadura (Spain)
Trial website
Publications
Contact name Prof  Narcis  Gusi
  Address Faculty of Sports Sciences
  City/town Caceres
  Zip/Postcode 10071
  Country Spain
  Tel +34 (0)92 725 74 60
  Fax +34 (0)92 725 74 61
  Email ngusi@unex.es
Sponsor University of Extremadura (Spain)
  Address Avda Elvas s/n
  City/town Badajoz
  Zip/Postcode 06071
  Country Spain
  Tel +34 (0)92 428 93 05
  Fax +34 (0)92 427 29 83
  Email vicein@unex.es
  Sponsor website: http://www.unex.es
Date applied 04/03/2006
Last edited 05/11/2009
Date ISRCTN assigned 20/04/2006
Submit your trial protocol
Submit to Trials journal
Follow us on Twitter
© 2012 ISRCTN unless otherwise stated.


BioMed Central